Advances in predicting T cell epitope recognition for cancer immunotherapy

Area of Science:

• Immunology
• Oncology
• Bioinformatics

Background:

• T cell recognition of cancer cells is crucial for effective cancer immunotherapy.
• This recognition involves interactions between T cell receptors (TCRs) and tumor-associated peptide antigens presented by major histocompatibility complex (MHC) molecules.
• Characterizing these interactions is essential for developing targeted cancer therapies.

Purpose of the Study:

• To review technological and computational advancements in understanding T cell-epitope recognition in cancer.
• To highlight the role of these advances in predicting antigenic peptides and TCR recognition.
• To explore the potential of leveraging TCR repertoire data for novel cancer immunotherapies.

Main Methods:

• Review of current sequencing technologies for genomic, transcriptomic, and epigenetic profiling of cancer cells.
• Analysis of T cell receptor (TCR) repertoire profiling techniques.
• Discussion of computational algorithms for epitope prediction and TCR-epitope interaction modeling.

Main Results:

• Technological advances enable comprehensive characterization of cancer neoantigens and TCR repertoires.
• Computational tools have significantly improved the accuracy of predicting T cell-recognized epitopes.
• Understanding TCR-epitope interactions provides insights into immune responses against cancer.

Conclusions:

• Integrating multi-omics data with TCR repertoire analysis is key to deciphering cancer immunity.
• Improved epitope prediction and TCR-epitope recognition understanding can drive the development of personalized cancer immunotherapies.
• Leveraging these insights holds promise for future therapeutic innovations in oncology.